Search research articles
Contact Us
Filters
Showing results (81-90 of 231) with videos related to
Page
of 24
Sort By:
Breast Care (Basel, Switzerland)
|
May 4, 2012
ABC1 Consensus Conference - a German Perspective: First International Consensus Conference on Advanced Breast Cancer (ABC1), Lisbon, November 5, 2011
Christoph Thomssen, Norbert Marschner, Michael Untch, et al.
Breast Cancer Research and Treatment
|
December 29, 2015
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Otto Metzger-Filho, Evandro de Azambuja, Marion Procter, et al.
Journal of the National Cancer Institute
|
July 18, 2013
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2024
Discussion of ABC7 Consensus and German Recommendations
Michael Untch, Nina Ditsch, Peter A Fasching, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 5, 2023
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trial
Marcus Schmidt, Ulrike Nitz, Toralf Reimer, et al.
Journal of the National Cancer Institute
|
March 4, 2014
Response
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Breast Care (Basel, Switzerland)
|
April 19, 2024
ABC7 Consensus: Assessment by a German Group of Experts
Nina Ditsch, Michael Untch, Peter A Fasching, et al.
Cancers
|
October 27, 2022
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis
Sandra M Swain, Harrison Macharia, Javier Cortes, et al.
Breast Care (Basel, Switzerland)
|
May 8, 2014
Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective
Nadia Harbeck, Norbert Marschner, Michael Untch, et al.
Breast Cancer Research and Treatment
|
September 20, 2020
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D)
Noam Pondé, Dominique Agbor-Tarh, Lissandra Dal Lago, et al.
Page
of 24
Search research articles
Search
Showing results (81-90 of 231) with videos related to
Sort By:
Page
of 24
Breast Care (Basel, Switzerland)
|
May 4, 2012
ABC1 Consensus Conference - a German Perspective: First International Consensus Conference on Advanced Breast Cancer (ABC1), Lisbon, November 5, 2011
Christoph Thomssen, Norbert Marschner, Michael Untch, et al.
Breast Cancer Research and Treatment
|
December 29, 2015
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Otto Metzger-Filho, Evandro de Azambuja, Marion Procter, et al.
Journal of the National Cancer Institute
|
July 18, 2013
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2024
Discussion of ABC7 Consensus and German Recommendations
Michael Untch, Nina Ditsch, Peter A Fasching, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 5, 2023
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trial
Marcus Schmidt, Ulrike Nitz, Toralf Reimer, et al.
Journal of the National Cancer Institute
|
March 4, 2014
Response
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Breast Care (Basel, Switzerland)
|
April 19, 2024
ABC7 Consensus: Assessment by a German Group of Experts
Nina Ditsch, Michael Untch, Peter A Fasching, et al.
Cancers
|
October 27, 2022
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis
Sandra M Swain, Harrison Macharia, Javier Cortes, et al.
Breast Care (Basel, Switzerland)
|
May 8, 2014
Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective
Nadia Harbeck, Norbert Marschner, Michael Untch, et al.
Breast Cancer Research and Treatment
|
September 20, 2020
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D)
Noam Pondé, Dominique Agbor-Tarh, Lissandra Dal Lago, et al.
Page
of 24